Carpal Tunnel Syndrome – Global Clinical Trials Review, 2022
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The carpal tunnel syndrome report provides a comprehensive overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on number of ongoing trials).
What are the market dynamics in the carpal tunnel syndrome clinical trials market?
The carpal tunnel syndrome clinical trial report consists of more than 200 trials. Trials conducted by companies are in Phase IV, Phase III, Phase II and Phase 0. Similarly, the trials with different status compile of completed, ongoing, planned, suspended, terminated and withdrawn.
What are the key regions in the carpal tunnel syndrome clinical trials market?
The key regions in the carpal tunnel syndrome clinical trials market are Asia-Pacific, Europe, North America, Middle East & Africa, and Central & South America.
Carpal tunnel syndrome clinical trials market in Asia -Pacific
Taiwan, India, Thailand, China, and South Korea are the top five countries in Asia-Pacific in the carpal tunnel syndrome clinical trials market. Among them, Taiwan has the highest number of trials, followed by India, Thailand, China, and South Korea.
Carpal tunnel syndrome clinical trials market in Europe
Italy, Spain, Turkey, United Kingdom, and Belgium are the top five countries in Europe in the carpal tunnel syndrome clinical trials market. Among them, Italy has the highest number of clinical trials, followed by Spain, Turkey, and the UK.
Carpal tunnel syndrome clinical trials market in North America
The US, Canada, and Mexico are the top countries in the carpal tunnel syndrome clinical trials market in North America. Among them the US has the highest number of clinical trials, followed by Canada and Mexico.
Carpal tunnel syndrome clinical trials market in Middle East & Africa
Middle East & Africa has the highest number of clinical trials in the global carpal tunnel syndrome clinical trials market. The top countries in the Middle East include Iran and Egypt. Iran has the highest number of clinical trials, followed by Egypt.
Carpal tunnel syndrome clinical trials market in Central & South America
Venezuela and Brazil are the top countries in the Central & South America in the carpal tunnel syndrome clinical trials market. Among them Venezuela has the highest number of clinical trials, followed by Brazil.
Carpal tunnel syndrome clinical trials market in G7 countries
The G7 countries in the clinical trials market include the US, the UK, Germany, France, Italy, Canada and Japan. Among them the US has the highest number of clinical trials.
Carpal tunnel syndrome clinical trials market in E7 countries
The E7 countries in the carpal tunnel syndrome clinical trials market include Brazil, Russia, India, China, Mexico, Turkey and Indonesia. India has the highest number of clinical trials among the E7 countries.
Carpal tunnel syndrome clinical trials market, by region
For more regional insights, download a free sample
Who are the key sponsors in the carpal tunnel syndrome clinical trials market?
Tri-Service General Hospital, Endo International Plc, Ono Pharmaceutical Co Ltd, Sumitomo Chemical Co Ltd, Thermo Fisher Scientific Inc, AbbVie Inc, Alfasigma SpA, Avadim Health Inc, Bristol-Myers Squibb Co, and Charles River Laboratories International Inc are the key sponsors in the carpal tunnel syndrome clinical trials market.
Carpal tunnel syndrome clinical trials market, by key sponsors
To know more about key sponsors, download a free sample
Market report scope
Key regions | Asia-Pacific, Europe, North America, Middle East & Africa, and Central & South America |
Key phases | Phase IV, Phase III/IV, Phase III, Phase II/III, Phase II, Phase 0 |
Key sponsors | Tri-Service General Hospital, Endo International Plc, Ono Pharmaceutical Co Ltd, Sumitomo Chemical Co Ltd, Thermo Fisher Scientific Inc, AbbVie Inc, Alfasigma SpA, Avadim Health Inc, Bristol-Myers Squibb Co, and Charles River Laboratories International Inc |
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type and end point status
- The report reviews top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended and withdrawn) with reason for failure
- The report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Endo International Plc
Ono Pharmaceutical Co Ltd
Sumitomo Chemical Co Ltd
Thermo Fisher Scientific Inc
AbbVie Inc
Alfasigma SpA
Avadim Health Inc
Bristol-Myers Squibb Co
Charles River Laboratories International Inc
Table of Contents
Frequently asked questions
-
What are the key regions in the carpal tunnel syndrome clinical trials market?
Asia-Pacific, Europe, North America, Middle East & Africa, and Central & South America are the key regions in the carpal tunnel syndrome clinical trials market.
-
Who are the key sponsors in the carpal tunnel syndrome clinical trials market?
Tri-Service General Hospital, Endo International Plc, Ono Pharmaceutical Co Ltd, Sumitomo Chemical Co Ltd, Thermo Fisher Scientific Inc, AbbVie Inc, Alfasigma SpA, Avadim Health Inc, Bristol-Myers Squibb Co, and Charles River Laboratories International Inc are the key sponsors in the carpal tunnel syndrome clinical trials market.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Central Nervous System reports

